Bill Commons

NY S 5786

in committee

Requires certain eligible persons or entities to acquire and possess opioid antagonists

New York · 2025-2026 Regular Session · upper

Quick answers

Did NY S 5786 pass?

Not yet. NY S 5786 is in committee as of 2026-01-07 and has not come to a final vote. Latest recorded action (2026-01-07): REFERRED TO HEALTH

What is NY S 5786 about?

Requires certain eligible persons or entities to acquire and possess opioid antagonists for emergency treatment of a person appearing to experience an opioid-related overdose.

Who sponsors NY S 5786?

Luis R. Sepúlveda is the primary sponsor of NY S 5786.

Description

Requires certain eligible persons or entities to acquire and possess opioid antagonists for emergency treatment of a person appearing to experience an opioid-related overdose.

Introduced
Latest action
2026-01-07 — REFERRED TO HEALTH
Bill type
bill
Last updated

Sponsors

  • Luis R. Sepúlvedaprimary

Committees

Not provided by source.

Action timeline

  1. 2025-03-03

    REFERRED TO HEALTH

    referral-committee

  2. 2026-01-07

    REFERRED TO HEALTH

    referral-committee

Versions

Documents

Votes

Not provided by source.

Related bills

  • Prior session: A 10187not in this corpus
  • Prior session: A 448not in this corpus
  • Prior session: A 576not in this corpus
  • Prior session: S 9583not in this corpus
  • Companion bill: A 1748

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z

Inspect retained evidence for changes recorded after evidence tracking began:

Session-wide evidence can include changes to other bills:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=S 5786. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.